131 related articles for article (PubMed ID: 19925287)
1. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients.
Roozbeh J; Hedayati P; Sagheb MM; Sharifian M; Hamidian Jahromi A; Shaabani S; Jalaeian H; Raeisjalali GA; Behzadi S
Ren Fail; 2009; 31(9):798-801. PubMed ID: 19925287
[TBL] [Abstract][Full Text] [Related]
2. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
3. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
[TBL] [Abstract][Full Text] [Related]
5. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
6. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients.
Rashidi AA; Salehi M; Piroozmand A; Sagheb MM
J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504
[TBL] [Abstract][Full Text] [Related]
7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
8. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
9. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
11. Assessment of lipid dysfunction in patients on maintenance haemodialysis.
Altaf A; Halim A; Khan DA; Khalid M; Fatima-Tuz-Zuhra ; Saif I
J Ayub Med Coll Abbottabad; 2007; 19(4):32-6. PubMed ID: 18693593
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations.
Shafran SD; Mashinter LD; Roberts SE
HIV Med; 2005 Nov; 6(6):421-5. PubMed ID: 16268824
[TBL] [Abstract][Full Text] [Related]
13. Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?
Nauck M; Krämer-Guth A; Bartens W; März W; Wieland H; Wanner C
Clin Nephrol; 1996 Nov; 46(5):319-25. PubMed ID: 8953121
[TBL] [Abstract][Full Text] [Related]
14. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.
Farvid MS; Siassi F; Jalali M; Hosseini M; Saadat N
Diabetes Res Clin Pract; 2004 Jul; 65(1):21-8. PubMed ID: 15163474
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of vitamin B-6 supplementation on the lipoprotein profile of post-menopausal chronic hemodialysis patients.
Pike S; Prati RC; Cochran C; Gorman MA; Ashby J; Liepa GU
J Am Diet Assoc; 1990 Jul; 90(7):968-72. PubMed ID: 2365939
[TBL] [Abstract][Full Text] [Related]
16. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
17. Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography.
Hirowatari Y; Yoshida H; Fueki Y; Ito M; Ogura Y; Sakurai N; Miida T
Ann Clin Biochem; 2008 Nov; 45(Pt 6):571-4. PubMed ID: 18782818
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
Diepeveen SH; Verhoeven GW; Van Der Palen J; Dikkeschei LD; Van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
J Intern Med; 2005 May; 257(5):438-45. PubMed ID: 15836660
[TBL] [Abstract][Full Text] [Related]
19. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fish oil supplementation for treatment of moderate elevation of serum cholesterol.
Valdini AF; Glenn MA; Greenblatt L; Steinhardt S
J Fam Pract; 1990 Jan; 30(1):55-9. PubMed ID: 2403586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
